Sedative-Hypnotic Use Disorder (2019) | Steven Batki, MD

This presentation is part of the Addiction Medicine Review Course 2019, an overview of the core elements of addiction medicine, presented by top experts in the field. Together with the other presentations it can serve as a broad review for clinicians, a review of the basics for newcomers, or a starting point for those preparing to sit for the ABPM Board Examination in Addiction Medicine. 

Learners cannot sign up for individual lectures, only for the full Addiction Medicine Review Course 2019. Please contact CSAM (csam@csam-asam.org) if you have any questions about this online educational offering. 

Target Audience

  • Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
  • Primary care clinicians who want to get a better understanding of addiction and manage patients with addictions in their practice
  • Public health officials who want an understanding of the current state of addiction treatment
  • Non-physicians who are involved in the treatment of addiction
Course summary
Available credit: 
  • 0.75 AMA Category 1
  • 0.75 Attendance
Course opens: 
08/16/2019
Course expires: 
09/01/2022
Cost:
$0.00
Part of: 
CSAM Review Course in Addiction Medicine 2019
Rating: 
0

Steven Batki, MD

Steven L. Batki, M.D. is Professor of Psychiatry at the University of California, San Francisco (UCSF) School of Medicine, Director of the Addiction Recovery Treatment Services at the San Francisco VA Medical Center where he also directs the Addiction Research Program and the UCSF/SFVAMC Addiction Psychiatry Fellowship Program. Previously, he served as Director of the Division of Substance Abuse and Addiction Medicine at San Francisco General Hospital. Dr. Batki also serves as the Addiction Psychiatry Consultant for Alta Mira Recovery Programs, a residential rehabilitation program in Sausalito, CA. Dr. Batki is engaged in addiction research, training, and clinical services. His research focuses on the pharmacological treatment of addiction and co-occurring psychiatric and medical disorders. His current NIDA-funded work studies the treatment of methamphetamine dependence, and his current VA-based research program focuses on the treatment of alcohol use disorder in veterans with co-occurring PTSD and mild TBI.

Nothing to disclose

 

CSAM 
The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.

CSAM designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credits™, Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Continuing education credit is available for psychologists, therapists, substance use counselors, nurses and physician assistants.

(see additional information on page for parent course)

Available Credit

  • 0.75 AMA Category 1
  • 0.75 Attendance

Price

Cost:
$0.00
Please login or register to take this course.